Point of view: Should COVID-19 patients be supplemented with vitamin D? - Archive ouverte HAL Access content directly
Journal Articles Maturitas Year : 2020

Point of view: Should COVID-19 patients be supplemented with vitamin D?

, , (1)
1
Cédric Annweiler
Zhijian Cao
  • Function : Author
Jean-Marc Sabatier

Abstract

Using Hill's methodology for exploring causality, we aimed to determine in early May 2020 whether evidence supports vitamin D as a biological determinant of COVID-19 outcomes. Vitamin D is a secosteroid hormone theoretically able to reduce COVID-19 risk through regulation of (i) the renin-angiotensin system, (ii) cellular innate and adaptive immunity, and (iii) physical barriers. Inverse associations were found between 25-hydroxyvitamin D concentrations and COVID-19 incidence and mortality. Randomized controlled trials testing vitamin D supplementation in the treatment of COVID-19 are in progress. Positive results in such studies would encourage the use of vitamin D supplements as an adjuvant treatment in COVID-19.

Dates and versions

hal-03170726 , version 1 (16-03-2021)

Identifiers

Cite

Cédric Annweiler, Zhijian Cao, Jean-Marc Sabatier. Point of view: Should COVID-19 patients be supplemented with vitamin D?. Maturitas, 2020, 140, pp.24-26. ⟨10.1016/j.maturitas.2020.06.003⟩. ⟨hal-03170726⟩
17 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More